StockDrifts LogoStockDrifts

Verdad Advisers 13F Portfolio

Portfolio Manager
Verdad Advisers LP
Performance
+27.80% (2026 Q2)
AUM (13F)
$104.41M
# of Holdings
210
Performance Rank
Allocation (Top 20)
30.68%
Latest filing
Q2 2026

Verdad Advisers LP Holdings Map

Top 50 Verdad Advisers LP Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
AAPL
APPLE INC
2.06%7.4K$2.2Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 4.2K shares2026-Q1: 0 shares2026-Q2: 7.4K shares
$233.05(+31.04%)
2026-06-30
BLTE
BELITE BIO INC
2.03%13.8K$2.1M
-0.40%(-55)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 13.8K shares2026-Q2: 13.8K shares
$159.70(+1.94%)
2026-06-30
ACAD
ACADIA PHARMACEUTICALS INC
2%82.6K$2.1M
+21.00%(+14.34K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 68.3K shares2026-Q2: 82.6K shares
$24.26(+16.41%)
2026-06-30
CMCSA
COMCAST CORP NEW
1.99%84.6K$2.1M
+103.54%(+43.02K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 105.0K shares2026-Q1: 41.5K shares2026-Q2: 84.6K shares
$27.71(-5.52%)
2026-06-30
CLDT
CHATHAM LODGING TR
1.77%140.0K$1.9M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 115.0K shares2026-Q1: 140.0K shares2026-Q2: 140.0K shares
$6.86(+89.26%)
2026-06-30
TENX
TENAX THERAPEUTICS INC
1.72%123.2K$1.8M
+29.21%(+27.84K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 95.3K shares2026-Q2: 123.2K shares
$14.13(-87.02%)
2026-06-30
SLDE
SLIDE INS HLDGS INC
1.69%91.1K$1.8M
+197.05%(+60.41K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 30.7K shares2026-Q2: 91.1K shares
$18.71(+17.19%)
2026-06-30
ZYME
ZYMEWORKS INC
1.67%66.7K$1.7M
-19.36%(-16.01K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 82.7K shares2026-Q2: 66.7K shares
$25.69(-2.20%)
2026-06-30
AMN
AMN HEALTHCARE SVCS INC
1.61%51.9K$1.7M
+3.81%(+1.91K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 45.0K shares2026-Q1: 50.0K shares2026-Q2: 51.9K shares
$17.80(+93.77%)
2026-06-30
XFOR
X4 PHARMACEUTICALS INC
1.57%352.1K$1.6Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 352.1K shares
$4.33(-1.15%)
2026-06-30

About Verdad Advisers LPโ€™s portfolio

Verdad Advisers LP reports $104.41M in US-listed equity holdings across 210 positions in its most recent 13F filing. Its largest disclosed positions are AAPL (2.1%), BLTE (2.0%) and ACAD (2.0%). The top 20 holdings account for 30.68% of reported assets. Its disclosed equity book has returned +75.87% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
AAPL โ€” 3.7% ($2.15M)BLTE โ€” 3.7% ($2.12M)ACAD โ€” 3.6% ($2.09M)CMCSA โ€” 3.6% ($2.08M)CLDT โ€” 3.2% ($1.85M)TENX โ€” 3.1% ($1.79M)SLDE โ€” 3.1% ($1.76M)ZYME โ€” 3.0% ($1.74M)AMN โ€” 2.9% ($1.68M)XFOR โ€” 2.8% ($1.64M)Other โ€” 67.3% ($38.89M)
33%in top 10
  • AAPL3.7%
  • BLTE3.7%
  • ACAD3.6%
  • CMCSA3.6%
  • CLDT3.2%
  • TENX3.1%
  • SLDE3.1%
  • ZYME3.0%
  • AMN2.9%
  • XFOR2.8%
  • Other67.3%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
16
AAPLAPPLE INC2.1%
XFORX4 PHARMACEUTICALS INC1.6%
JBIOJADE BIOSCIENCES INC1.2%
CSCOCISCO SYS INC1.2%
+12 opened
Added to
20
SLDESLIDE INS HLDGS INC+197.1%
CMCSACOMCAST CORP NEW+103.5%
VSNTVERSANT MEDIA GROUP INC+129.0%
WHWKWHITEHAWK THERAPEUTICS INC+161.1%
+16 more
Trimmed
12
RVMDREVOLUTION MEDICINES INC-81.2%
AMATAPPLIED MATLS INC-62.4%
NRIXNURIX THERAPEUTICS INC-40.7%
DSGNDESIGN THERAPEUTICS INC-48.5%
+8 more

Unlock alerts, watchlists & AI chat

Sign up free to track Verdad Advisers LP, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Verdad Advisers LPโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1812822). View Verdad Advisers LPโ€™s 13F filings on SEC

More 13F analyses

View all